行情

BDSI

BDSI

BioDelivery科学国际
NASDAQ

实时行情|Nasdaq Last Sale

5.16
+0.01
+0.19%
盘后: 5.16 0 0.00% 16:00 10/18 EDT
开盘
5.12
昨收
5.15
最高
5.17
最低
5.11
成交量
79.57万
成交额
--
52周最高
5.37
52周最低
2.800
市值
4.62亿
市盈率(TTM)
-8.9537
分时
5日
1月
3月
1年
5年

分析师评级

7位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

BDSI 新闻

  • Moving Average Crossover Alert: BioDelivery Sciences International
  • Zacks.2天前
  • Will BioDelivery Sciences Continue to Surge Higher?
  • Zacks.2天前
  • New Strong Buy Stocks for October 17th
  • Zacks.3天前
  • From Iqvia to Cree: Execs with ties to Triangle companies inked millions in Q3 stock sales
  • American City Business Journals.10/07 19:50

更多

所属板块

制药
-0.90%
制药与医学研究
-0.94%

热门股票

名称
价格
涨跌幅

BDSI 简况

BioDelivery Sciences International, Inc. is a specialty pharmaceutical company. The Company develops and commercializes, either on its own or in partnerships with third parties, applications of approved therapeutics to address unmet medical needs using drug delivery technologies. The Company develops pharmaceutical products aimed principally in the areas of pain management and addiction. The Company's products utilize the BioErodible MucoAdhesive (BEMA) drug delivery technology, a small, erodible polymer film for application to the buccal mucosa (the lining inside the cheek). The Company's United Sates Food and Drug Administration (FDA) approved product, ONSOLIS (fentanyl buccal soluble film), as well as its approved products BUNAVAIL (buprenorphine and naloxone buccal film) buccal film and BELBUCA (buprenorphine) buccal film, utilize BEMA technology.
展开

Webull提供BioDelivery Sciences International, Inc.的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。